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Respiratory function testing in adults and older children is
used to aid diagnosis, evaluate severity of disease and
monitor response to treatment. It is only in the past 15
years that an interest in infant lung function tests (ILFT)
has developed, coincident with the advance of computer
technology and the electronic engineering skills necessary to
manufacture equipment of sucient sensitivity and accu-
racy for assessing infants. Conventional methods, such as
whole body plethysmography, require expensive and
complicated equipment that is technically demanding to
use. Recent interest has focused on developing simpler
techniques that are more suitable for routine clinical
assessment and research. Although many techniques are
still undergoing evaluation and are restricted to a limited
number of centres, information about the early growth
and development of the lungs in health and disease is
beginning to accumulate. In addition, ILFT may add to the
clinician’s tools in characterizing the severity and type of
respiratory illness in the very young, and also allow the
assessment of response to therapeutic manoeuvres. With
further developments and expansion of services it is
possible that premorbid prediction of disease will enable
the instigation of early intervention strategies, allowing
disease prevention.
Difficulties in performing lung
function tests in infants
Measurement of respiratory parameters in infants was
attempted over 100 years ago using spirometry to assess
tidal volume and respiratory rate. The large dead space of
the equipment made readings inaccurate and it was not
until the advent of plethysmography in the 1930s that
reasonably reliable recordings of tidal breathing were made.
Measurements of infant lung volume using gas dilution
were described in the 1950s, and, by the 1960s, pneumo-
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mography became established for measuring functional
residual capacity (FRC), and later modifications of the
technique allowed measurement of airway resistance (1).
However, it is only in the past few decades that interest in
the measurement of infant respiratory physiological para-
meters has really developed. There are a number of reasons
for the relatively slow development of this discipline (Table
1). Infants are unable to cooperate with special respiratory
manoeuvres and any measurements outside the tidal
breathing range require innovative techniques to be used.
Some techniques require the baby to be in quiet sleep, and
because the duration of testing tends to be long, sleep needs
to be augmented by sedative medication in all but the
youngest of subjects. Equipment is often bulky and
expensive. Interpretation of the data is time-consuming
and can be tedious. Reference data remain limited because
of the ethical issues surrounding the sedation of healthy
infants for tests that will be of little benefit to the individual.
Infants are preferentially nasal breathers, with nasal
resistance accounting for 50% of total airway resistance.
Nasal pathology, most commonly a recent viral infection,
can therefore mask lower respiratory tract abnormalities.
The chest wall is extremely compliant in babies and the low
outward recoil results in a low and unstable FRC and the
tendency to airway closure during tidal breathing. Diculty
in achieving flow limitation and the normal variability of
airway resistance in this age group both hamper the
assessment of changes in respiratory function in response
to challenges or therapeutic interventions. Perhaps most
importantly, the very infants in whom the disease process
requires further definition and understanding are the ones
whose illnesses make testing dicult.
Although measuring the respiratory function of infants
remains more dicult than in adults, techniques continue
to improve. Recent international collaborative eort
between groups interested in this discipline have allowed
the establishment of the European Respiratory Society
Taskforce on the Standardization of Infant Respiratory
Function Testing and the publication of a number of
important documents (2–5).
Characteristics of a good respiratory
function test
Lung function tests in infants should be performed under
the direction of a clinician trained in the relevant techniques# 2000 HARCOURT PUBLISHERS LTD
TABLE 2. Research applications of ILFT
Current research applications include investigations of:
. The normal early growth and development of the lungs.
. Infant physiology in health and disease.
. Premorbid features of disease.
. The influence of environmental and genetic factors
preconception, in utero and in early life on pulmonary
development and disease.
TABLE 3. Infant lung function tests as a clinical tool
The ideal test should answer the following questions:
. Does the infant have evidence for respiratory
dysfunction? If so, what is the nature and severity of
this dysfunction?
. What is the prognosis?
. Has the therapeutic intervention improved pulmonary
function?
. Has the respiratory dysfunction worsened or resolved?
TABLE 1. Diculties in performing ILFT
^ Physiological problems
. high upper airway resistance may mask lower airway
abnormalities
. unstable FRC
. flow limitation is dicult to achieve
^ Infants unable to cooperate
^ Infant often required to be in quiet sleep
^ Bulky, expensive equipment
^ Data interpretation
. time consuming
. limited reference data
642 J. S. LUCAS ET AL.and aware of the limitations of the test. No single
pulmonary function test provides a comprehensive range
of the information likely to be required by the investigator,
who should ensure that the tests chosen will provide the
information required to answer the research or clinical
question they are wishing to address.
When choosing an appropriate test the investigator will
consider:
. Which test will provide the most useful information
under conditions acceptable to both the patient and the
investigator;
. the purpose of the test;
. the age of the infant.
In order to provide good quality data and to reduce both
inter- and intra-laboratory variability, meticulous testing
procedures need to be followed, and these should be
supervised by operators who have undertaken the correct
training and have obtained an appropriate level of
expertise.
Multi-disciplinary working groups have attempted to
identify the characteristics of the ideal ILFT (6).
The ideal infant lung function test should:
. be acceptable to the individual to be tested;
. not be an onerous time constraint for the individual
being tested;
. be easy, rapid and safe to administer;
. be able to be completed in the field or outside of
specialized laboratories;
. be sensitive and specific;
. be able to measure the dierent components of the
respiratory system;
. have consistent and reproducible test results;
. be available at a relatively low cost.
The safety record of current test procedures is excellent,
but caution is required as with all investigations. Infants
should be assessed prior to testing, and tests should not
proceed if the risks exceed the degree of benefit likely to be
obtained from performing these tests. Guidelines to ensure
safety of the infant have been published (7).
Many of the recommended ideals are not yet fulfilled by
current methodologies, which are confined to use inspecialized laboratories or intensive care settings. As
further progress is made, and equipment suitable for wide
scale manufacture is designed, infant lung function testing
will move closer to these ideals.
What can be measured and how?
Tests of pulmonary function in infants can be used to
explore the normal functional development of the lungs,
understand their mechanical properties and assess both the
eects of disease and responses to therapeutic interventions
(Tables 2 and 3). It is vital that the clinician or researcher
understands the application and limitations of the tests he
performs.
INDICES OF TIDAL BREATHING
Various measurements can be measured during tidal
breathing. Respiratory rate and tidal volume are relatively
easy to measure but are dicult to interpret because the
process of measurement may influence the baby’s breathing
pattern. Minute ventilation is measured to study control of
breathing, particularly in response to carbon dioxide and
hypoxia. Time to peak expiratory flow (tPTEF) as a ratio of
total expiratory time (te) is easily calculated from tidal
breathing measurements. Studies have found tPTEF/tE is
reduced in male infants who subsequently progress to
having wheezing illness (8) and infants whose mothers
smoked during pregnancy. This would suggest an associa-
tion between small calibre airways and reduced tPTEF/tE.
However, a study in which airway obstruction was induced
in infants using histamine failed to show a significant
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Thus, the significance of this measurement remains
controversial and the reason for a relationship with
obstructive airway disease remains speculative.
Measurement of tidal volume, rate, tPTEF/tE and minute
ventilation in infants are usually made in the supine
position during quiet sleep. The baby breathes sponta-
neously through a facemask with a leak-free seal. Inspired
and expired gas flow can then be measured using a low
dead-space pneumotachograph (PNT) at the airway open-
ing. In ventilated infants the PNT is at the end of the
tracheal tube. Flow is usually measured directly, and this is
integrated to provide volume data. The dierential pressure
transducer used for the PNT can measure airway pressure.
Because the PNT directly measures flow at the airway
opening, it is the gold standard by which other methods are
validated.
A thermistor can be used to detect flow-related tempera-
ture changes at the airway opening. The time of response to
temperature change is such that the data produced does not
accurately represent the true flow waveform, rendering
them useful only for qualitative determination of airflow
and timing respiratory rate. Alternatively, measurement of
thoracic and abdominal movement can be used to sense
respiratory eort even in the absence of airway flow.
Measurement of chest wall movements using strain gauges,
impedance plethysmography and pressure capsules is easy
and non-invasive. These methods have the advantage of not
altering respiratory patterns. They are useful for measuring
respiratory rate and detecting central apnoea, but with the
exception of some types of strain gauge, these devices are
not suitable for accurate determination of timing indices or
volume change.
LUNG VOLUMES
Measurements of lung volumes are important for the
understanding of pulmonary development, and can assist in
interpreting measurements of lung mechanics that are
volume dependent such as resistance and compliance.
Functional residual capacity (FRC) is the only lung volume
that can easily be measured repeatedly and reliably in
infants. Total lung capacity (TLC) and residual volume
(RV) can be estimated from forced inflation and deflation
manoeuvres, but these measurements require tracheal
intubation. TLC and RV have been estimated from
measuring vital capacity during crying but these estimates
have poor reproducibility and are not routinely used.
FRC is most commonly measured by body plethysmo-
graphy or gas dilution. Measurement of FRC using body
plethysmography is based on techniques used in adults. It
has the advantage of measuring airway resistance simulta-
neously (1). Plethysmography measures the volume of all
the gas in the lungs at the moment of occlusion, including
any trapped behind narrow or closed airways. The major
drawback is the complicated and expensive equipment,
which has confined its use to a few specialized respiratory
laboratories. Improvements in equipment and computer
software are likely to make its use more widespread.FRC can also be measured using helium dilution or
nitrogen washout techniques in infants who are usually
asleep and supine. Again, these methods are similar to those
used in adults. Gas dilution techniques measure the lung
volume that equilibrates with the inspired gas during tidal
breathing, and therefore only measure areas of the lung in
direct communication with the central airways. The
measurements of FRC are consistently lower with gas
dilution than plethysmography for reasons that are not
fully understood, but include air trapping and poor gas
mixing.
There is a growing interest in the use of imaging
techniques for assessing lung volumes (10,11).
FORCED EXPIRATORY MEASUREMENTS
Measurements of peak expiratory flow and other forced
expiratory flow indices have a central role in the diagnosis
and management of adults and older children with
intrathoracic airway disease. Although infants cannot
comply with instructions to perform forced expiratory
manoeuvres, the rapid thoraco-abdominal compression
technique (RTC) allows study of forced expiratory flow in
infants by creating partial expiratory flow-volume (PEFV)
curves. Controversy exists regarding whether flow limita-
tion is achieved using this method (4) and, without true flow
limitation, comparisons between and within individuals are
unreliable. RTC technique measurements made during tidal
breathing use FRC as the volume landmark to calculate
maximum flow at FRC (V’max, FRC). FRC can be unstable
in infants and can be influenced by factors such as sleep
state, addition of dead space and changes in airway calibre.
This may explain the very high variability of V’max, FRC.
Adaptations of RTC involve increasing the lung volume
immediately prior to the compression (see below). This
technique allows measurement of timed expiratory volumes
such as FEV0?75 or FEV0?5, thus avoiding the need for a
volume landmark and providing data with much improved
intra- and inter-subject variability. Non-quantitative data is
also informative. The partial expiratory flow-volume curve
in infants with obstructive airway disease shows significant
concavity whereas the normal curve should be convex
(Figs 1, 2 and 3).
Rapid thoraco-abdominal compressions (RTCs) require
a fitted inflatable jacket to be wrapped around the sleeping
infant’s abdomen and thorax. The jacket should be loose
enough to allow the chest to fully expand. The infant
breathes spontaneously through a facemask with PNT as
described for measuring tidal breathing indices. The jacket
is rapidly inflated at end-inspiration, producing a forced
expiration. The RTC is repeated at increasing jacket
pressures from 40 to a maximum of 100 cm H2O until
there is no further increase in flow despite increasing
pressure. This is the pressure at which flow limitation
occurs. Maximal flow at FRC is then calculated from the
PEFV curve.
This technique has now been adapted with the RTC
following passive inflation of the lungs to near total lung
capacity (Fig. 4). The lung volume is raised by positive
FIG. 1. Convex partial expiratory flow-volume curve. This
little girl is 1 year old and had ILFT as part of her regular
health check as she has cystic fibrosis. The curve suggests
good pulmonary function at the time of testing.
FIG. 2. Concave partial expiratory flow-volume curve.
This is the curve of an asymptomatic 6-week-old boy who
has ILFT as part of an epidemiological study. His flow
volume curve shows a slight concavity suggestive of mild
obstructive airways disease. This finding is consistent with
a slightly lower than predicted V’max FRC result. He will be
observed throughout his first year of life to see if he
becomes symptomatic.
FIG. 3. Infant with severe obstructive airways disease. This
infant has severe obstructive airways disease. There was a
small degree of improvement of her V’max FRC when a
bronchodilator was administered and tests repeated.
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nization with the infant’s breathing. This manoeuvre
relaxes the respiratory muscles by invoking the Hering
Breuer reflex. At the end of a relaxed inspiration the jacket
is inflated to the pressure identified as being optimal for the
collection of RTCs data, and timed expiratory flow is
calculated made from the expiratory curve.FIG. 4. Raised volume RTC curve.
TABLE 4. Specific clinical applications of infant lung
function tests
Current clinical applications:
. Evaluation of therapeutic interventions (surfactant,
b-agonists, adrenergics, steriods).
. To aid diagnosis of obstructive airway disease.
. Evaluation of secondary lung involvement in congenital
heart disease and neuromuscular disease.
. To assess lung growth and development following the
use of various types of ventilatory assistance (such as
ECMO).
. To optimise artificial ventilatory parameters thus
decreasing the likelihood of the infant developing a
pnemothorax or intraventricular hemorrhage.
. To make serial measurements to assess the severity and
the progression of lung disease (as in chronic lung
disease or bronchopulmonary dysplasia).
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Measurements of bronchial responsiveness are important as
a research tool. Methacholine, histamine and cold air have
all been used as provocative agents. Initial studies measured
the fall in V’max,FRC (12,13). More recently FEVt has been
shown to decrease significantly in infants with a history of
recurrent wheeze after provocation with histamine (14). As
well as the technical problems of conducting the ILFT, the
standardization of the dose of bronchodilator or bronch-
oconstrictor delivered from a nebulizer or spacer device
must be considered.
RESISTANCE AND COMPLIANCE
Methods for measuring compliance and resistance can be
classified as passive or dynamic. Dynamic mechanics are
measured during spontaneous breathing or mechanically
assisted respiration, and passive mechanics during man-
oeuvres that induce relaxation of the respiratory muscles.
All techniques require the simultaneous measurement of
flow, volume and pressure.
Passive mechanics measurements rely on eliciting the
vagally-mediated Hering Breuer reflex by airway occlusion
at volumes above FRC, causing complete relaxation of the
inspiratory and expiratory muscles. The measurements can
be performed in spontaneously breathing or mechanically
ventilated infants, using a pneumotachograph and shutter.
The most commonly used techniques are the multiple
occlusion technique (MOT) for measurements of respira-
tory system compliance (Crs) and the single breath
technique (SBT) for respiratory system compliance (Crs),
resistance (Rrs) and time constant (trs). In the MOT, brief
airway occlusions are performed at dierent levels above
FRC during expiration, which cause the respiratory
muscles to relax and airway pressure to equilibrate. The
pressure at the airway outlet is measured and, assuming
equilibrium with the pressure in the lungs, this reflects the
elastic recoil pressure of the respiratory system. Crs is
calculated from the volume-pressure plot. The SBT is
performed by occluding the airway at end-inspiration to
induce relaxation. Crs, Rrs and trs are calculated from the
passive flow-volume curve and the airway opening pressure
measured during the occlusion. Multiple measurements are
made and the mean value calculated.
Dynamic lung mechanics can be calculated in infants by
accurately measuring airflow, tidal volume and transpul-
monary pressure. These measurements can be performed in
both spontaneously breathing and mechanically ventilated
infants. Body plethysmography can also be used for
measuring airway resistance (Raw), but its use is limited
by the technically demanding methodology and the need
for complex, expensive equipment.
The measurements of dynamic lung resistance (RL) and
compliance (CL) require the measurement of transpulmon-
ary pressure, which is usually approximated by oesophageal
manometry. An oesophageal balloon or flexible catheter
tipped microtransducer is sited in the lower third of the
oesophagus. A pneumotachograph measures flow, which isintegrated to obtain volume. The measurements are
technically demanding, and measured values may be
aected by upper airway resistance or the resistance of
the equipment. Also, oesophageal catheters are poorly
tolerated in many infants.
Clinical and epidemiological
applications
Although infant lung function tests were originally devel-
oped to aid in the assessment of the severity of a number of
known obstructive respiratory disorders, in recent years
these tests have developed more as a research tool with
particular reference to normal growth and development of
the respiratory system in late gestation and early life
(Table 4).
Longitudinal epidemiological studies combining testing
of premorbid airway function in early life and subsequent
clinical assessment of wheezing have led to a better
understanding of the importance of early life events, and
genetic and environmental factors (15–18). It is anticipated
that increasingly it will be possible to identify those at
greater risk of developing respiratory disease, such as
asthma, by the use of these techniques.
Measurements of lung function are rarely diagnostic in
themselves and there is much controversy regarding the
value of pulmonary function testing as a clinical tool (19).
The optimal clinical use of ILFTs at the present time is for
repeated tests over a period of time, reviewing disease
progression and resolution and examining an individual
infant’s response to intervention therapies (Table 5). As yet,
standardized reference data is not widely available, and
without this it is dicult to assess objectively the value of
any one individual infant’s results. More is needed to
understand which lung function test will address specific
clinical questions and will oer the best index to inform
clinical management (Table 3).
TABLE 5. Research agenda
Further work is needed:
. To develop simpler methods of testing and data analysis
suitable for routine application.
. To standardise equipment, testing conditions,
methodology and data analysis.
. To establish normal reference data.
. To define the sensitivity and specificity of individual
methodologies.
. To establish diagnostic features of the disease.
. To define premorbid features predictive of future
disease.
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normative data becomes available infant lung function
testing as a clinical tool will grow in value.
Data collection
Research studies should be hypothesis-driven and the
research question identified before data collection com-
mences. The study population, recruitment methods and
inclusion and exclusion criteria should be clearly defined.
Power-based calculations of sample size should be per-
formed. In addition to the ILFT data, information
regarding demographic factors and possible confounding
variables should be recorded. Stratification techniques
should be employed where necessary. Information about
infants who are approached for recruitment but who do not
participate or fail to complete the study should be
documented. A detailed record of the methods used to
collect data must be made, including technical details of
equipment and whether sedation was used. Testing of
clinical subjects requires similar procedures to ensure good
quality, reproducible data.
Parental consent should be obtained for all investigations
on an infant. This should follow a full explanation of the
procedures involved. Approval of the relevant Ethics
Committee is also necessary if the investigation is for
research purposes.
Many lung function test protocols require the infant to
be in quiet sleep. Data collected during active sleep is likely
to be of poor quality not only because of irregular
respiratory eorts, but also because glottic closure and
expiratory braking are common. This creates a dicult
ethical situation, because sedation is associated with
increased risk, but the data obtained without such
medication may be of inferior quality.
The most commonly used drugs are chloral derivatives
and midazolam. Their pharmacokinetics and side eects
have been reviewed by a joint working group of the
American Thoracic Society and European Respiratory
Society (3). Although many studies have failed to show
significant changes in respiratory rate, oxygen saturation,
FRC or V’maxFRC with triclofos or chloral hydrate, onestudy demonstrated a significant rise in respiratory rate.
Sedation is contraindicated in infants with known upper
airway obstruction, and care should be taken in babies with
a history of acute life-threatening events, in wheezy infants
and in infants with hepatic, renal or cardiac disease.
Continuous monitoring of vital signs and pulse oximetry
are mandatory throughtout the period of sedation in all
infants.
If appropriate precautions are taken, chloral derivatives
are safe and provide good testing conditions. A single dose
of chloral hydrate, 50–100 mg kg71, eectively augments
sleep but the baby will stir or wake to inappropriate stimuli.
For each of the techniques mentioned above, full metho-
dological details can be found in ‘Infant Respiratory
Function Testing’ (2).
Data analysis and interpretation
Reference ranges taken from epidemiological studies are
frequently used when interpreting data obtained from
infants with clinical disease. This enables the clinician to
establish whether the data falls within the range expected
for a given age, gender and body size. The significance of
data from an individual falling within or outside the given
range depends on the quality of the normative data used
and its appropriate application. If the scatter of the
reference data is great due to wide biological variability
or poor repeatability, a baby with disease may fall within
the ‘normal’ range. The reference values should have been
obtained under the same testing conditions as the
laboratory using them, and the method of selection and
size of the sample population should be known. Ideally,
each ILFT laboratory should generate its own normative
reference data. Realistically, few centres are likely to study
sucient numbers of healthy infants of each age, gender
and ethnic group. However, published data from large
studies of healthy infants or combined data from several
laboratories that have a standardized testing procedure
exist (5).
The need for standardization of both equipment and
methodology, and an understanding of the limitation of
tests is clear. Quality control of data, and the exclusion of
inappropriate or inadequate data from analysis is also
important. Although most of the analysis of data is aided
by computer software, the visual inspection of each piece of
data by an experienced individual is a vital part of the
procedure. Only data that is technically acceptable by both
visual and measured standards should be included for
analysis. For example, features of glottic closure seen on a
flow-volume loop may eliminate that breath from further
analysis even if computer-generated analysis appears
acceptable. Visually viewing the data also identifies
qualitative abnormalities that may not be readily defined
by quantitative analysis. For example, a concave partial
expiratory flow-volume curve is suggestive of obstructive
airway disease.
Test results are only meaningful if they are derived from
testing procedures which follow established, standardized
protocols. Every ILFT laboratory should have a carefully
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should be assessed regularly (3). The final report of each
test should contain information about testing conditions,
reproducibility and quality of results.
Summary
Although the earliest reliable lung function tests in infants
were performed as long as 40 years ago, there has only
recently been a growth in this area, as simpler methods and
better equipment and IT resources have been developed.
Exciting information is accumulating about the normal
physiology and pathology of the infant lung. Many basic
questions are still unanswered and the ability to perform
these tests remains confined to a few specialized centres. To
co-ordinate the development of ILFT and establish
standardization in a number of areas including measure-
ment conditions, equipment specifications, methodology
protocols and data analysis, international collaboration is
necessary between the teams working in this field (Table 5).
Collaborative groups are currently addressing these issues
and are also developing recommendations regarding the
design of randomized clinical trials, multi-centre studies
and research agendas.
Infant lung function testing remains primarily a research
tool. Our aim should be not only to refine and develop the
techniques of physiological measurement but to apply
ILFT to the objective study of respiratory illness in infants
in the clinical setting so as to aid in the prevention and
treatment of these common, debilitating and costly
diseases.
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